Zobrazeno 1 - 10
of 543
pro vyhledávání: '"E. Carmeliet"'
Autor:
Peter J. Schwartz, Michael R. Rosen, D. P. Zipes, S. Izumo, José Jalife, Charles Antzelevitch, Michiel J. Janse, Dan M. Roden, J. A. Camm, Andrew R. Marks, W. A. Catterall, E. Marban, G. I. Fishman, H. A. Fozzard, P. M. Spooner, S. Ogawa, C. T. January, P. S. Matteo, Alfred L. George, A. G. Kléber, Penelope A. Boyden, Albert L. Waldo, M. Hiraoka, Yoram Rudy, E. Carmeliet, J. M. Weiss
Publikováno v:
ResearcherID
Autor:
Jurg J. Van der Walt, Johannes M. Van Rooyen, T.Stefanus Kellerman, Edward E. Carmeliet, Fons Verdonck
Publikováno v:
European Journal of Pharmacology. 329:201-211
Publikováno v:
Cardiovascular Research. 28:741-745
Autor:
E. Carmeliet
Publikováno v:
Fundamental & Clinical Pharmacology. 7:19-28
K+ channels form a large family, in which voltage-operated and ligand-operated channels can be distinguished. Under physiological conditions, four K+ currents contribute to the repolarization process and their role is discussed: i) the transient outw
Reduction of ischemic K+ loss and arrhythmias in rat hearts. Effect of glibenclamide, a sulfonylurea
Publikováno v:
Circulation Research. 66:478-485
Glibenclamide, one of the antidiabetic sulfonylureas, is known to block ATP-dependent K+ channels. We used this drug to determine to what extent K+ loss from acutely ischemic myocardium is mediated via these channels. We also investigated whether gli
Autor:
A, Allessie, M, Avkiran, M, Borggrefe, E, Carmeliet, S M, Cobbe, S, Dhein, W, Haverkamp, G, Hindricks, M J, Janse, A G, Kléber
Publikováno v:
European heart journal. 16(11)
Autor:
B. I. Sasyniuk, E. Carmeliet
Publikováno v:
Pharmacological Sciences: Perspectives for Research and Therapy in the Late 1990s ISBN: 9783034872201
The results of the Cardiac Arrhythmia Suppression Trial (CAST) highlighted the inadequacy of therapy with class I antiarrhythmic drugs in patients with ischemic heart disease and served as an impetus for the search for new antiarrhythmic strategies [
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::09ac2b9af968865c6fa789b48138aabd
https://doi.org/10.1007/978-3-0348-7218-8_34
https://doi.org/10.1007/978-3-0348-7218-8_34
Autor:
E. Carmeliet
Publikováno v:
Antiarrhythmic Drugs ISBN: 9783642856266
Recently attention among clinicians and arthythmologists has shifted from the study of class I drugs acting on the Na+ channel to class III drugs or drugs prolonging the action potential duration. The immediate reason was the Cardiac Arrhythmia Suppr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::efe0b2cefa6514344ef5f6cca7290b93
https://doi.org/10.1007/978-3-642-85624-2_5
https://doi.org/10.1007/978-3-642-85624-2_5
Autor:
E. Carmeliet, J. Vereecke
Publikováno v:
Myocardial Ischemia and Arrhythmia ISBN: 9783642725074
Among the early changes in ion concentration during myocardial ischemia the rise in extracellular K+ concentration is the most pronounced. Four possible mechanisms are proposed and evaluated. They are not mutually exclusive and all probably play a ro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1416de188fd1351cfee44472b9fbac42
https://doi.org/10.1007/978-3-642-72505-0_4
https://doi.org/10.1007/978-3-642-72505-0_4
Autor:
E. Carmeliet
Publikováno v:
European heart journal. 14
This paper describes and discusses interventions that may lead to prolongation of the action potential. Special emphasis is given to regulation by drugs. The results of studies focusing on the modulation of inward and outward currents are presented i